en Experimental Neurobiology

Cited by CrossRef (30)

  1. Taavi Vanaveski, Jane Narvik, Jürgen Innos, Mari-Anne Philips, Aigar Ottas, Mario Plaas, Liina Haring, Mihkel Zilmer, Eero Vasar. Repeated Administration of D-Amphetamine Induces Distinct Alterations in Behavior and Metabolite Levels in 129Sv and Bl6 Mouse Strains. Front. Neurosci. 2018;12
    https://doi.org/10.3389/fnins.2018.00399
  2. Shreshth Khanna, Suchita Pant, Harsh Khanna. Isoniazid-Induced Psychosis in a Patient with Pulmonary Tuberculosis: A Case Report. Case Rep Neurol 2023;15:76
    https://doi.org/10.1159/000530779
  3. Josh M. Krivinko, Jeremy Koppel, Alena Savonenko, Robert A. Sweet. Animal Models of Psychosis in Alzheimer Disease. The American Journal of Geriatric Psychiatry 2020;28:1
    https://doi.org/10.1016/j.jagp.2019.05.009
  4. Julie Berg, Gathi Abraham, Adelaide Robb, Finza Latif. Biochemical and Molecular Basis of Pediatric Disease. 2020.
    https://doi.org/10.1016/B978-0-12-817962-8.00033-0
  5. Zdeněk Fišar. Biological hypotheses, risk factors, and biomarkers of schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2023;120:110626
    https://doi.org/10.1016/j.pnpbp.2022.110626
  6. Rachna Gupta, Muktika Tekade, Nupur Vasdev, Tanisha Gupta, Bhakti Pawar, Kuldeep Kumar Bansal, Rakesh Kumar Tekade. Essentials of Pharmatoxicology in Drug Research, Volume 1. 2023.
    https://doi.org/10.1016/B978-0-443-15840-7.00006-3
  7. Christine L. Miller. The Epigenetics of Psychosis: A Structured Review with Representative Loci. Biomedicines 2022;10:561
    https://doi.org/10.3390/biomedicines10030561
  8. I. А. Fedotov, D. Quattrone, D. I. Shustov. Substance-induced psychosis and schizophrenia: the interaction point. I.P. Pavlov Russian Medical Biological Herald 2020;28:593
    https://doi.org/10.23888/PAVLOVJ2020284593-604
  9. Lea Tomašić, Mirta Peček, Zrnka Kovačić Petrović. Substance-Induced Psychosis: a Narrative Review. Curr Addict Rep 2023;11:55
    https://doi.org/10.1007/s40429-023-00528-w
  10. Michelle Cherro, Chonnakarn Jatchavala, DJibril I.M. Handuleh, Ramdas Ransing, Sheikh Shoib, Dorottya Őri, Margaret Isioma Ojeahere, Joan Soler-Vidal, Victor Pereira-Sanchez. Substance-induced or substance-associated primary psychoses? Continuing the discussion. A response to I.А. Fedotov, et al. I.P. Pavlov Russian Medical Biological Herald 2021;29:171
    https://doi.org/10.23888/PAVLOVJ2021291171-176
  11. Serge Weis, Michael Sonnberger, Andreas Dunzinger, Eva Voglmayr, Martin Aichholzer, Raimund Kleiser, Peter Strasser. Imaging Brain Diseases. 2021.
    https://doi.org/10.1007/978-3-7091-1544-2_50
  12. Stefania Schiavone, Luigia Trabace. The use of antioxidant compounds in the treatment of first psychotic episode: Highlights from preclinical studies. CNS Neurosci Ther 2018;24:465
    https://doi.org/10.1111/cns.12847
  13. Pauline Stoltzner, Cameron Duncan. Casting shadows of perception. 2024;49:20
    https://doi.org/10.1097/01.NPR.0000000000000139
  14. Wenji He, Xinyu Yan, Sanqiang Pan. Amphetamine Neurotoxicity in PC12 Cells through the PP2A/AKT/GSK3β Pathway. Neurotox Res 2018;34:233
    https://doi.org/10.1007/s12640-018-9880-8
  15. Marco Colizzi, Sagnik Bhattacharyya. Risk Factors for Psychosis. 2018.
    https://doi.org/10.1016/B978-0-12-813201-2.00016-8
  16. E. Leterme, W. De Troyer, L. Renier. Scopolamine als bestanddeel van een magistrale bereiding als zeldzame oorzaak van visuele hallucinaties. Tijdschr Geneesk 2021
    https://doi.org/10.47671/TVG.77.21.186
  17. Abdullah Al-Hamid, Carys Tudor, Sulaf Assi. Exploring profile, effects and toxicity of novel synthetic opioids and classical opioids via Twitter: A qualitative study. Emerging Trends in Drugs, Addictions, and Health 2024;4:100139
    https://doi.org/10.1016/j.etdah.2023.100139
  18. M. Carmen Arenas, Sergio Pujante-Gil, Carmen Manzanedo. Methods for Preclinical Research in Addiction. 2024.
    https://doi.org/10.1007/978-1-0716-1748-9_3
  19. Alessio Fiorentini, Filippo Cantù, Camilla Crisanti, Guido Cereda, Lucio Oldani, Paolo Brambilla. Substance-Induced Psychoses: An Updated Literature Review. Front. Psychiatry 2021;12
    https://doi.org/10.3389/fpsyt.2021.694863
  20. Chieh-Liang Huang, I-Ju Tsai, Cynthia Wei-Sheng Lee. Risk of psychosis in illicit amphetamine users: a 10 year retrospective cohort study. Evid Based Mental Health 2022;25:163
    https://doi.org/10.1136/ebmental-2021-300300
  21. Po-An Chen, Hui-Yi Wang, Chien-Lun Sun, Mao-Liang Chen, Yi-Chyan Chen, Chih-Yuan Ko. Neurobehavioral Differences of Valproate and Risperidone on MK-801 Inducing Acute Hyperlocomotion in Mice. Behavioural Neurology 2022;2022:1
    https://doi.org/10.1155/2022/1048463
  22. Tetsuo Ohnishi, Shabeesh Balan, Manabu Toyoshima, Motoko Maekawa, Hisako Ohba, Akiko Watanabe, Yoshimi Iwayama, Yuko Fujita, Yunfei Tan, Yasuko Hisano, Chie Shimamoto-Mitsuyama, Yayoi Nozaki, Kayoko Esaki, Atsuko Nagaoka, Junya Matsumoto, Mizuki Hino, Nobuko Mataga, Akiko Hayashi-Takagi, Kenji Hashimoto, Yasuto Kunii, Akiyoshi Kakita, Hirooki Yabe, Takeo Yoshikawa. Investigation of betaine as a novel psychotherapeutic for schizophrenia. EBioMedicine 2019;45:432
    https://doi.org/10.1016/j.ebiom.2019.05.062
  23. Andrea Mastinu, Margrate Anyanwu, Marinella Carone, Giulia Abate, Sara Anna Bonini, Gregorio Peron, Emanuela Tirelli, Mariachiara Pucci, Giovanni Ribaudo, Erika Oselladore, Marika Premoli, Alessandra Gianoncelli, Daniela Letizia Uberti, Maurizio Memo. The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology. IJMS 2023;24:1329
    https://doi.org/10.3390/ijms24021329
  24. L. Aparicio-Nava, L.A. Márquez-García, A. Meneses. Effects of 5-HT5A receptor blockade on amnesia or forgetting. Behavioural Brain Research 2019;357-358:98
    https://doi.org/10.1016/j.bbr.2018.01.009
  25. Kinga Gawel, Nancy Saana Banono, Agnieszka Michalak, Camila V. Esguerra. A critical review of zebrafish schizophrenia models: Time for validation?. Neuroscience & Biobehavioral Reviews 2019;107:6
    https://doi.org/10.1016/j.neubiorev.2019.08.001
  26. Angela N. Phan, Garth E. Terry. Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder. Front. Psychiatry 2023;14
    https://doi.org/10.3389/fpsyt.2023.1144276
  27. So Hyeon Park, Yoo Sung Song, Byung Seok Moon, Byung Chul Lee, Hyun Soo Park, Sang Eun Kim. Combination of In Vivo [123I]FP-CIT SPECT and Microdialysis Reveals an Antipsychotic Drug Haloperidol-induced Synaptic Dopamine Availability in the Rat Midbrain and Striatum. Exp Neurobiol 2019;28:602
    https://doi.org/10.5607/en.2019.28.5.602
  28. Dr Gurpreet Bhamra. Drug induced psychosis. InnovAiT: Education and inspiration for general practice 2023;16:456
    https://doi.org/10.1177/17557380231177321
  29. Kelsey S. Hideshima, Ashkhan Hojati, Justin M. Saunders, Doan M. On, Mario de la Fuente Revenga, Jong M. Shin, Ana Sánchez-González, Cassandra M. Dunn, Alexander B. Pais, Anthony C. Pais, Michael F. Miles, Jennifer T. Wolstenholme, Javier González-Maeso. Role of mGlu2 in the 5-HT2A receptor-dependent antipsychotic activity of clozapine in mice. Psychopharmacology 2018;235:3149
    https://doi.org/10.1007/s00213-018-5015-4
  30. Anton M. Lakstygal, Tatiana O. Kolesnikova, Sergey L. Khatsko, Konstantin N. Zabegalov, Andrey D. Volgin, Konstantin A. Demin, Vadim A. Shevyrin, Edina A. Wappler-Guzzetta, Allan V. Kalueff. DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens. ACS Chem. Neurosci. 2019;10:2144
    https://doi.org/10.1021/acschemneuro.8b00615